StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Piper Sandler boosted their price target on Amphastar Pharmaceuticals from $43.00 to $55.00 in a research note on Thursday, June 15th. Amphastar Pharmaceuticals Stock Down 2.1 % […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) EVP Rong Zhou sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $51.79, for a total value of $258,950.00. Following the transaction, the executive vice president now owns 96,888 shares in the […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) EVP Rong Zhou sold 5,000 shares of the business’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $51.79, for a total value of $258,950.00. Following the completion of the sale, the executive vice president now directly owns 96,888 shares […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) EVP Rong Zhou sold 5,000 shares of the company’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $51.79, for a total value of $258,950.00. Following the sale, the executive vice president now owns 96,888 shares of the company’s stock, […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) had its price target boosted by Piper Sandler from $43.00 to $55.00 in a research report sent to investors on Thursday, The Fly reports. Separately, StockNews.com lowered Amphastar Pharmaceuticals from a strong-buy rating to a buy rating in a research note on Tuesday, June 13th. Amphastar Pharmaceuticals Trading Up […]